✦ LIBER ✦

Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial

✍ Scribed by Bengala, C; Bertolini, F; Malavasi, N; Boni, C; Aitini, E; Dealis, C; Zironi, S; Depenni, R; Fontana, A; Del Giovane, C

Book ID: 110000267
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 266 KB
Volume: 102
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6605458

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of gemcitabine combined w

Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas

✍ Jeeyun Lee; Tae-You Kim; Myung Ah Lee; Myung Ju Ahn; Hoon-Kyo Kim; Ho Yeong Lim; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 246 KB

Gemcitabine and oxaliplatin in advanced

Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study

✍ André, T; Reyes-Vidal, J M; Fartoux, L; Ross, P; Leslie, M; Rosmorduc, O; Clemen 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

Phase II trial of uracil/tegafur (UFT) p

Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma

✍ Sridhar Mani; David Sciortino; Brian Samuels; Rose Arrietta; Richard L. Schilsky 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 52 KB

Phase II trial of sorafenib in combinati

Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma

✍ Iacopo Petrini; Monica Lencioni; Miriam Ricasoli; Mauro Iannopollo; Cinzia Orlan 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 261 KB

A phase I/II trial of sorafenib and infl

A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma

✍ Larkin, J M G; Ferguson, T R; Pickering, L M; Edmonds, K; James, M G; Thomas, K; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 226 KB

A phase II trial of gemcitabine in patie

A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma

✍ Charles S. Fuchs; Jeffrey W. Clark; David P. Ryan; Mathew H. Kulke; Haesook Kim; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract ## BACKGROUND There is no effective systemic therapy for patients with hepatocellular carcinoma. A recent trial reported a moderate antitumor activity for gemcitabine among Asian patients with advanced hepatocellular carcinoma. This led to our examination of the efficacy and tolerabili